Entrepreneurs show interest in negotiating the purchase of vaccines against Covid-19 for themselves and their employees, but this initiative will not be easily completed. This is because the Pharmaceutical Products Industry Union (Sindusfarma) informed that the associated pharmaceutical companies do not want to negotiate the sale of the immunizing agent to the private sector.
In a statement, the organization said that the companies AstraZeneca, Butantan, Janssen and Pfizer are negotiating, supplying and distributing their coronavirus vaccines exclusively to federal governments and international public health organizations.
“At this moment, no company or individual is authorized to negotiate on behalf of these companies that produce vaccines against Covid-19 with any public or private entity, whether directly or indirectly,” says the statement.
The Chamber of Deputies is expected to vote next week on project No. 948, of 2021, presented by Deputy Hildo Rocha (MDB / MA), which authorizes the purchase of vaccines against Covid-19 by private companies. Currently, the legislation allows the acquisition, as long as the immunizers are donated to the Unified Health System (SUS).
The intention of the project would be for companies to pass on only half of the vaccines to SUS. The rest could be used for free application in employees, interns, freelancers and outsourced workers, as well as in family members of the entrepreneurs.
Get the latest news delivered to your inbox
Follow us on social media networks